Patients with metabolic dysfunction-associated steotohepatitis (MASH) who are already taking a glucagon-like peptide-1 receptor agonist (GLP-1RA) could see their liver health improve with the addition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback